WELLS FARGO & COMPANY/MN - TALIS BIOMEDICAL CORP ownership

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of TALIS BIOMEDICAL CORP
ValueSharesWeighting
Q2 2023$84
+2.4%
174
+4.2%
0.00%
Q1 2023$82
+12.3%
167
+1.8%
0.00%
Q4 2022$73164
+3.1%
0.00%
Q3 2022$0159
+51.4%
0.00%
Q2 2022$0
-100.0%
105
-96.6%
0.00%
Q1 2022$4,000
-87.5%
3,072
-61.7%
0.00%
Q4 2021$32,000
-85.2%
8,023
-59.0%
0.00%
Q2 2021$216,000
+307.5%
19,557
+372.6%
0.00%
Q1 2021$53,0004,1380.00%
Other shareholders
TALIS BIOMEDICAL CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Greenlight Capital 2,235,783$1,095,5340.06%
Baker Brothers Advisors 7,624,835$3,736,1690.02%
PRELUDE CAPITAL MANAGEMENT, LLC 223,934$109,7280.01%
ArrowMark Colorado Holdings LLC 478,862$234,6420.00%
WELLS FARGO & COMPANY/MN 167$820.00%
NORTHERN TRUST CORP 27,860$13,6520.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 144,416$70,7630.00%
STATE STREET CORP 49,536$24,2730.00%
MILLENNIUM MANAGEMENT LLC 163,663$800.00%
View complete list of TALIS BIOMEDICAL CORP shareholders